[
  {
    "ts": "2025-10-14T11:51:39+00:00",
    "headline": "Gilead and Arcus reignite anti-TIGIT interest with Phase II gastric cancer win",
    "summary": "These results could rekindle the anti-TIGIT flame, which was once burning bright in pharma pipelines.",
    "url": "https://www.clinicaltrialsarena.com/news/gilead-arcus-anti-tigit-domvanalimab-phase-ii/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "fb4e447d-0b91-39d4-a2ae-39620639df58",
      "content": {
        "id": "fb4e447d-0b91-39d4-a2ae-39620639df58",
        "contentType": "STORY",
        "title": "Gilead and Arcus reignite anti-TIGIT interest with Phase II gastric cancer win",
        "description": "",
        "summary": "These results could rekindle the anti-TIGIT flame, which was once burning bright in pharma pipelines.",
        "pubDate": "2025-10-14T11:51:39Z",
        "displayTime": "2025-10-14T11:51:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/a8da33a7522aa3c68484f5b1f7e4fe4b",
          "originalWidth": 1000,
          "originalHeight": 506,
          "caption": "Gilead and Arcus Biosciences' anti-TIGIT mAb",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fe1bZeoq2bhayZNXCrpMcA--~B/aD01MDY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/a8da33a7522aa3c68484f5b1f7e4fe4b.cf.webp",
              "width": 1000,
              "height": 506,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CswnqOEz9XeCuPkUXV1Wcw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/a8da33a7522aa3c68484f5b1f7e4fe4b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/gilead-arcus-anti-tigit-domvanalimab-phase-ii/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-arcus-reignite-anti-tigit-115139794.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]